{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6q6LoKDA","lastupdate":"2023-09-18T00:00:00.000Z","update_date":"2023-09-18T00:00:00.000Z","lastModified":"Sep 21, 2024","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"beta-o2","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$iGVi0RI41XjWOxW2B4WzbLq1N35GdyM1vk1uOCv05RzTR9HIMY9FRX.jpeg","name":"Beta-O2 Technologies","oneliner":"Implantable Bioreactor for Treating Type 1 Diabetes","registrar":"512870221","website":"https://beta-o2.com","careerspage":"","founded_month":1,"founded_year":2004,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/beta_o2","youtube":"https://www.youtube.com/channel/UC2oiNa51DDXUzJPcGvVI0Lg","facebook":"https://www.facebook.com/Beta-O2-Technologies-Ltd-715701275277592","linkedin":"https://www.linkedin.com/company/10999514","instagram":""},"social":["https://www.youtube.com/channel/UC2oiNa51DDXUzJPcGvVI0Lg","https://www.facebook.com/Beta-O2-Technologies-Ltd-715701275277592","https://www.linkedin.com/company/10999514","https://twitter.com/beta_o2"],"flattenedsociallinks":"https://www.youtube.com/channel/UC2oiNa51DDXUzJPcGvVI0Lg|https://www.facebook.com/Beta-O2-Technologies-Ltd-715701275277592|https://www.linkedin.com/company/10999514|https://twitter.com/beta_o2","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":15,"patent":1,"raised":8225000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["beta O2 technologies"],"about":"Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of patients with type 1 diabetes.\r\n\r\nThe Air is a small medical device that is implanted in a minimally invasive procedure. The device, which contains islets of Langerhans, is intended to free patients from insulin injections and continuous monitoring of glucose levels. The device also reduces the risk of hypoglycemic episodes and other complications of the condition.\r\n\r\nBecause the Air device contains living cells, the patient needs to refill the air in the device using a replenishing device, which includes a dedicated injector.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97239180700|+972525490408","country":null,"address":{"israeli":[{"id":"e66b7fb4-241f-4316-bf83-59f741421be9","city":"Rosh Haayin","type":null,"address":"Amal Street 11, Rosh Haayin, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"bcxEjr7q9qoySeyryAmPvbom7cVaQ4Lri0gbSAgQ3wfUKfz4u1FIPS","date":"Mar 16, 2020","link":"https://www.bioworld.com/articles/433748-beta-o2-technologies-to-begin-human-trials-on-new-artificial-pancreas?v=preview","source":"www.bioworld.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"R8iG8FZEB60Ejvb2i8EjJg9zUtOaeRWm0YIK6QTomO4wVCZruswWkK","news_summary":"Beta-O2 Technologies to begin human trials on new artificial pancreas","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"af02bd93-c889-4f16-9f5d-1ff570926661","date":"Sep 12, 2019","link":"https://www.jpost.com/Israel-News/Hillels-Tech-Corner-Using-tech-to-replicate-the-pancreas-601531","source":"www.jpost.com","visible":1,"analysis":{"tags":"medical technology","company":"Beta-O2 Technologies","layoffs":null,"summary":"Beta-O2 Technologies has developed a device called ßAir® that replaces the pancreas and monitors and controls glucose levels in the human body. The device offers a safe environment for transplanted cells without the need for immune-suppressive drugs. The company has completed two human trials and plans to conduct a second trial in 2020. Beta-O2 has raised $40 million in funding from various investors. If successful, the device could greatly improve the management of type-1 diabetes.","partners":null,"customers":null,"investors":["Sherpa Ventures","Aurum Ventures","Kai-Ming","investors from Japan"],"confidence":9,"key_topics":["diabetes","glucose monitoring","pancreas replacement","transplantation","clinical trials"],"date_of_event":"2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"69wkHjlR7I8X9xmqr26HnKlqYFNJ4uNOyoELAu8DOw119Pakk3KtPK","news_summary":"https://www.jpost.com/Israel-News/Hillels-Tech-Corner-Using-tech-to-replicate-the-pancreas-601531","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c90449e3-be0d-4486-be16-5bdeb3f80ebf","date":"Apr 26, 2018","link":"https://www.diabetes.co.uk/news/2018/apr/positive-breakthrough-made-in-implanted-islet-cells-technology-90204764.html","source":"www.diabetes.co.uk","visible":1,"analysis":{"tags":"implanted islet cell technology","company":"Beta-O2 Technologies","layoffs":null,"summary":"A breakthrough in implanted islet cell technology by MIT and Beta-O2 Technologies could lead to successful treatment for people with type 1 diabetes. The technology provides living pancreatic islet cells with their own supply of oxygen through an implantable device. Tests on rats showed that 90% of the islets survived for several months and blood sugar levels remained normal. Further development is underway to create a more sophisticated version of the device. The findings have been published in the journal Scientific Reports.","partners":["Massachusetts Institute of Technology (MIT)"],"customers":null,"investors":null,"confidence":8,"key_topics":["implanted islet cell technology","oxygen supply","type 1 diabetes","MIT","Beta-O2 Technologies"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KLBwuqnv1USRX5Ghrlfi91czv4L7bu85sXO8JyRaNdsCKiQeOEuN4Y","news_summary":"Positive breakthrough made in implanted islet cells technology - Diabetes","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"81c921c6-3fdf-4049-94c4-a29214f33437","date":"Dec 3, 2017","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3726468,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"IPO, investment","company":"Internet Research Institute Inc.","layoffs":null,"summary":"Internet Research Institute Inc., a Tokyo-headquartered tech holding company, plans to raise $20-$30 million through an IPO on the Tel Aviv Stock Exchange. The company, which registered in Israel in August, aims to bring Israeli technologies and ideas to the Japanese market in the domains of IoT, cybersecurity, and AI. The IPO underwriter is Discount Capital Underwriting Ltd., and the funds raised will be used for local research and development or acquisitions and investments. Internet Research Institute has annual revenues of $8 million and net profits of around $2 million. In September, the company invested $200 thousand in Beta-O2 Technologies Ltd., a biotech company. The IPO is expected to have a positive impact on the companys growth.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["IPO","investment","Israeli technologies","IoT","cybersecurity"],"date_of_event":"August","valuation_amount":"$50-$100 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Public Trading","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Public Trading  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7fnqhKhFsbsc6IoeGRLTkH9TLyVWoW9NMo0LoO5McItqNrgyqEU8wa","news_summary":"Japanese Technology Holding Company IRI Wants to Raise $30 Million in Tel Aviv IPO","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7e0e6488-5730-4f8f-8aa8-a9e13d946f07","date":"Aug 22, 2016","link":"http://www.globes.co.il/en/article-fda-decision-renews-prospects-for-israel-diabetes-co-1001147508","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical technology","company":"Beta-O2 Technologies","layoffs":null,"summary":"Beta-O2 Technologies, an Israeli diabetes company, has developed a device that contains living pancreas cells that automatically secrete insulin into the bloodstream. The US Food and Drug Administration (FDA) has recently implemented a regulation requiring companies that implant insulin-secreting stem cells to use such a device. This regulation has sparked interest in Beta-O2 Technologies, as they have been working on a similar product for over a decade. The company is currently examining partnerships with various stem cell companies, including Kadimastem Ltd. The device has undergone successful trials with live cells, but not yet with stem cells.","partners":["Kadimastem Ltd."],"customers":null,"investors":null,"confidence":9,"key_topics":["diabetes","insulin","stem cells","artificial pancreas","regulation"],"date_of_event":"August 22, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kyRffELo6gKxC1P77wktg1wRJb6oCoHGYAH0I3IvhpaRl6yFQDl3Rk","news_summary":"FDA decision boosts Beta-02's artificial pancreas","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d2e66db2-e35a-4321-a277-4e17373ac1c0","date":"Mar 30, 2015","link":"http://www.finsmes.com/2015/03/beta-o2-technologies-receives-investment-from-sherpa-innoventures.html","source":"www.finsmes.com","visible":1,"analysis":{"tags":"investment","company":"Beta-O2 Technologies","layoffs":null,"summary":"Beta-O2 Technologies, a biomedical company based in Israel, has received an investment from Sherpa Innoventures. The funding will be used to accelerate the companys clinical development of the ßAir bio-artificial Pancreas for type 1 diabetes and other pipeline products. The company is led by CEO Dr. Yuval Avni and is also backed by Aurum Ventures, SCP Vitalife Partners, Pitango Venture Capital, and Saints Capital.","partners":null,"customers":null,"investors":"Sherpa Innoventures","confidence":8,"key_topics":["Beta-O2 Technologies","Sherpa Innoventures","investment","clinical development","ßAir bio-artificial Pancreas"],"date_of_event":"2015-03-31","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"1m9FiOOSr2RhT0IXYYLGnGqU7QLplt63PTWv0oMENBAh1J1DhmPGCZ","news_summary":"Beta-O2 Technologies Receives Investment from Sherpa Innoventures - FinSMEs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2fd42ff2-9b6f-4047-ad17-444b27e31046","date":"Nov 17, 2014","link":"http://www.israel21c.org/headlines/beta-o2-testing-cure-for-type-1-diabetes/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"bio-artificial pancreas","company":"Beta-O2","layoffs":null,"summary":"Israels Beta-O2 has implanted its ßAir bio-artificial pancreas in the first of eight diabetes patients in Sweden as part of a pilot human study. The implantable system aims to provide a potential cure for type 1 diabetes by protecting transplanted islet cells from the immune reaction to foreign matter and ensuring a consistent supply of oxygen. The company plans to use human stem cells and animal-derived cells in future experiments. If successful, the device could simulate the functionality of a functioning pancreas in response to varying glucose levels. Beta-O2 is backed by lead investor Aurum Ventures.","partners":null,"customers":null,"investors":"Aurum Ventures","confidence":8,"key_topics":["diabetes","implant","encapsulation","oxygen supply","islet cells"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"V7NJ3fVHxTs1wlzLqdb7x5epYfpFLEKXRyVo4pSHLn2MIHj1T7568r","news_summary":"Beta-O2 testing cure for type 1 diabetes","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"87da9c8e-f088-48a3-9900-ea1b3a4a4e10","date":"Oct 22, 2014","link":"http://www.globes.co.il/en/article-beta-o2-starts-clinical-trial-for-artificial-pancreas-1000980034","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical technology","company":"Beta-O2 Technologies","layoffs":null,"summary":"Beta-O2 Technologies has successfully implanted the first patient participating in the companys study of the ßAir Bio-Artificial Pancreas, a potential treatment and cure for type 1 diabetes. The study, funded by a grant from JDRF, aims to evaluate the safety and efficacy of the ßAir macro-encapsulation with human islets of Langerhans. If successful, the company estimates that an efficacy trial among 50 patients will be necessary before marketing the product. Beta-O2 Technologies has raised $23 million since its founding and estimates the entire process will cost $15-20 million. The companys investors include SCP Vitalife, Aurum Ventures, Pitango Venture Capital, and Saints.","partners":null,"customers":null,"investors":["SCP Vitalife","Aurum Ventures","Pitango Venture Capital","Saints"],"confidence":9,"key_topics":["Bio-Artificial Pancreas","Type 1 Diabetes","Clinical Trial","Encapsulation Technology","Insulin Injections"],"date_of_event":"October 22, 2014","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"s7q4YED9h2aTLfO8mJ006ADUMvtXAq80XLEpW2V0kziFhgNfqSdBwm","news_summary":"Beta-O2 starts clinical trial for artificial pancreas","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f01f2acb-92a5-409a-83ad-1b03aa84bd56","date":"Sep 10, 2014","link":"http://www.diabetesdaily.com/voices/2014/09/implantable-device-automatically-regulates-blood-sugar/","source":"www.diabetesdaily.com","visible":1,"analysis":{"tags":["implantable device","bio-artificial pancreas","type 1 diabetes","insulin","glucagon","JDRF","grant","stem-cell therapy","oxygen injections"],"company":"Beta-O2 Technologies Ltd.","layoffs":null,"summary":"The JDRF has announced a $500,000 grant to Beta-O2 Technologies Ltd. for their ßAir bio-artificial pancreas, which aims to eliminate the need for insulin injections and carbohydrate counting for type 1 diabetes patients. The grant will fund a pilot human study of the device. Beta-O2 has developed a special delivery system that protects the implanted cells from the bodys immune system and uses daily injections of oxygen to feed the cells. The technology has shown success in animal models and one human patient trial. Beta-O2 hopes to have patient trials running in Europe by 2016 and expects approval in Europe by 2019 or 2020. The technology is expected to be available to the public in the US several years after that.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["implantable device","bio-artificial pancreas","type 1 diabetes","insulin","glucagon"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tXC568whvxk8APfkTNGD6QZeGiiaGTwqtA8yIHbwXclxRsB2NeGMyY","news_summary":"Future Tech: Beta-O2 Announces Implantable Device to Automatically Manage Blood Sugars","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":9,"techcommunityinvolvement":null,"mediagallery":[{"id":"da9822ad-b15f-4aa8-84d3-ae8876c934ad","timestamp":"2020-07-21 10:27:04.000000","resources_type":2,"resources_title":"","resources_file_name":"elBhzleIwHI","alt":"","imageurl":"https://img.youtube.com/vi/elBhzleIwHI/0.jpg","url":"http://youtu.be/elBhzleIwHI"},{"id":"be20e1ae-6e43-48f2-9468-d8f66933a12b","timestamp":"2018-01-07 20:25:05.000000","resources_type":1,"resources_title":"","resources_file_name":"$d78nA6IsgWzQvxPeTQESdb2RcRm1VaeEwQzIxMqXjb5yfxrMfZRLmQ","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$d78nA6IsgWzQvxPeTQESdb2RcRm1VaeEwQzIxMqXjb5yfxrMfZRLmQ","url":"https://storage.googleapis.com/clean-finder-353810/$d78nA6IsgWzQvxPeTQESdb2RcRm1VaeEwQzIxMqXjb5yfxrMfZRLmQ"}],"tags":["biotechnology","minimally-invasive","diabetes","medical-devices"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Air Bio-Artificial Pancreas"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":5,"lastfunding":"$25K","totalrounds":6,"fundingstage":"Mature","totalfunding":"$8.22M","publicinvestors":4,"lastpublicfunding":25000,"totalpublicrounds":5,"totalpublicfunding":3225000},"team":[{"name":"Uriel Barkai","email":"uriel@beta-o2.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNb6044KDA","bounced":true,"claimed":0,"founder":0,"urlname":"uriel-barkai-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgscSuigkM","position":"CSO","last_name":"Barkai","claimtoken":"kgQdv50ld8a8iZ3FHxTpUQyvufXggrWJE37n5K6DLOUPLCcnP0qe7k","first_name":"Uriel","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/uriel-barkai-9a0a2330/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-09-18 15:26:59.000000","initials":"UB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Avi Rotem","email":"avi@beta-o2.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoLaw7owJDA","bounced":true,"claimed":0,"founder":0,"urlname":"avi-rotem-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg1pDk4QsM","position":"CTO","last_name":"Rotem","claimtoken":"7365b14ec77d87735cafce46263fecb7ec0313ac422a40379102d7eaa2967a2b","first_name":"Avi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/avi-rotem-604926135/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-07-21 10:29:24.000000","initials":"AR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2019-10-20T00:00:00.000Z","crunchbaseid":"beta-o2-technologies","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":"Tamar Weiss","creator_email":"tamar.e.weiss@gmail.com","createdate":"2014-08-11T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwKKcCAw","date":"Jan 2018","amount":"$25K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sherpa InnoVentures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sherpa-innoventures","logokey":"$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","tagline":null,"urlname":"/investor_page/sherpa-innoventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMq2hJwLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fdfbfd55-04a4-4abc-acc4-c61482c7420e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":25000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjcWuCQw","date":"Sep 2017","amount":"$200K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Internet Research Institute (IRI)","type":"Company","amount":0,"hidden":true,"country":"Japan","fullurl":"/company_page/internet-research-institute-iri","logokey":"$JW0hxHyDIhrsFtsTUbksarpFu6lpP1IhXzuaReKco1CcHzfp9XTxkL","tagline":"","urlname":"/company_page/internet-research-institute-iri","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD428uuCAw","fundingtype":"Company","leadpartner":null,"investmentid":"fd9e82f6-6be8-4932-8f35-c11489525c01","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JW0hxHyDIhrsFtsTUbksarpFu6lpP1IhXzuaReKco1CcHzfp9XTxkL","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":200000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE9rzzCww","date":"Mar 2015","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sherpa InnoVentures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sherpa-innoventures","logokey":"$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","tagline":null,"urlname":"/investor_page/sherpa-innoventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMq2hJwLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8c64ae9b-90d1-4949-85fb-56591c63412b","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE9ryjCAw","date":"Sep 2014","amount":"$1M","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"JDRF","type":"Investor","amount":0,"hidden":true,"country":"United States","fullurl":"/investor_page/jdrf","logokey":"$7Tw3LcUIsGqsBFG45dCk73YDIaVi5PSB8PAOKNIRz40FfpZZLQd3oC","tagline":"","urlname":"/investor_page/jdrf","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEjd7zCQw","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"cf5d2d34-0641-4060-bd16-a3b5e29653c3","fundingsubtype":"Equity Crowdfunding","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7Tw3LcUIsGqsBFG45dCk73YDIaVi5PSB8PAOKNIRz40FfpZZLQd3oC","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"32n935GWbvIuiGbi5b6io05iQnivEuBFoZmBqys5RQxEe9dlT8LfDb","date":"Feb 2007","amount":"$5M","source":"PB","eventtype":"FundingRoundEvent","investment":[{"name":"Aurum Ventures M.K.I","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/aurum-ventures-m-k-i","logokey":"$uXqANKdr2psLpFOAfFyTKSsOPyt0rXwR3tmuP8hHG2ppkNRUVhkEzt","tagline":null,"urlname":"/investor_page/aurum-ventures-m-k-i","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJGY5J8JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"M4CRU5gsMb1wCN1SO1yt4iBRMpQV9b382dwxXQMkMuld6DjP35dD18","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$uXqANKdr2psLpFOAfFyTKSsOPyt0rXwR3tmuP8hHG2ppkNRUVhkEzt","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Private","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"private-visibility","fundingvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5ZGDCAw","date":"Mar 2004","amount":"$2M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"SCP Vitalife","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/scp-vitalife","logokey":"$TyfWACBDu3BOb9eodv9xAcJ9GEsrfMgp8CYZOMixTusvVV9wc20mqD","tagline":null,"urlname":"/investor_page/scp-vitalife","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnPn5EKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"51083697-3145-40fb-9112-6a61e6ece4c4","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TyfWACBDu3BOb9eodv9xAcJ9GEsrfMgp8CYZOMixTusvVV9wc20mqD","leadcaption":"","followupcaption":""},{"name":"Heznek Fund","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/heznek-fund","logokey":null,"tagline":"","urlname":"/investor_page/heznek-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD4u4ShCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d03d501c-3c81-4854-ad3b-90e3905a7f7e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2004","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Beta-O2 Technologies","logourl":"https://storage.googleapis.com/clean-finder-353810/$iGVi0RI41XjWOxW2B4WzbLq1N35GdyM1vk1uOCv05RzTR9HIMY9FRX.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$iGVi0RI41XjWOxW2B4WzbLq1N35GdyM1vk1uOCv05RzTR9HIMY9FRX.jpeg","seoabout":"Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of patients with type 1 diabetes.\r...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Biomaterials & Tissue Engineering","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Biomaterials & Tissue Engineering"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"},{"title":"Providers","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Cells","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Cells"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Biomaterials & Tissue Engineering","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Biologicals","Cells"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwKKcCAw","date":"Jan 2018","amount":"$25K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sherpa InnoVentures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sherpa-innoventures","logokey":"$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","tagline":null,"urlname":"/investor_page/sherpa-innoventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMq2hJwLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fdfbfd55-04a4-4abc-acc4-c61482c7420e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":25000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjcWuCQw","date":"Sep 2017","amount":"$200K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Internet Research Institute (IRI)","type":"Company","amount":0,"hidden":true,"country":"Japan","fullurl":"/company_page/internet-research-institute-iri","logokey":"$JW0hxHyDIhrsFtsTUbksarpFu6lpP1IhXzuaReKco1CcHzfp9XTxkL","tagline":"","urlname":"/company_page/internet-research-institute-iri","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD428uuCAw","fundingtype":"Company","leadpartner":null,"investmentid":"fd9e82f6-6be8-4932-8f35-c11489525c01","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JW0hxHyDIhrsFtsTUbksarpFu6lpP1IhXzuaReKco1CcHzfp9XTxkL","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":200000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE9rzzCww","date":"Mar 2015","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sherpa InnoVentures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sherpa-innoventures","logokey":"$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","tagline":null,"urlname":"/investor_page/sherpa-innoventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMq2hJwLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8c64ae9b-90d1-4949-85fb-56591c63412b","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$9fzdMlswSCBhpDFBvvCcejvble5DMAEYtupLFYlcbzrm5D6wXpQv2c","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"32n935GWbvIuiGbi5b6io05iQnivEuBFoZmBqys5RQxEe9dlT8LfDb","date":"Feb 2007","amount":"$5M","source":"PB","eventtype":"FundingRoundEvent","investment":[{"name":"Aurum Ventures M.K.I","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/aurum-ventures-m-k-i","logokey":"$uXqANKdr2psLpFOAfFyTKSsOPyt0rXwR3tmuP8hHG2ppkNRUVhkEzt","tagline":null,"urlname":"/investor_page/aurum-ventures-m-k-i","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJGY5J8JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"M4CRU5gsMb1wCN1SO1yt4iBRMpQV9b382dwxXQMkMuld6DjP35dD18","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$uXqANKdr2psLpFOAfFyTKSsOPyt0rXwR3tmuP8hHG2ppkNRUVhkEzt","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Private","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"private-visibility","fundingvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5ZGDCAw","date":"Mar 2004","amount":"$2M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"SCP Vitalife","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/scp-vitalife","logokey":"$TyfWACBDu3BOb9eodv9xAcJ9GEsrfMgp8CYZOMixTusvVV9wc20mqD","tagline":null,"urlname":"/investor_page/scp-vitalife","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnPn5EKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"51083697-3145-40fb-9112-6a61e6ece4c4","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TyfWACBDu3BOb9eodv9xAcJ9GEsrfMgp8CYZOMixTusvVV9wc20mqD","leadcaption":"","followupcaption":""},{"name":"Heznek Fund","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/heznek-fund","logokey":null,"tagline":"","urlname":"/investor_page/heznek-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD4u4ShCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d03d501c-3c81-4854-ad3b-90e3905a7f7e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE9ryjCAw","date":"Sep 2014","amount":"$1M","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"JDRF","type":"Investor","amount":0,"hidden":true,"country":"United States","fullurl":"/investor_page/jdrf","logokey":"$7Tw3LcUIsGqsBFG45dCk73YDIaVi5PSB8PAOKNIRz40FfpZZLQd3oC","tagline":"","urlname":"/investor_page/jdrf","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEjd7zCQw","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"cf5d2d34-0641-4060-bd16-a3b5e29653c3","fundingsubtype":"Equity Crowdfunding","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7Tw3LcUIsGqsBFG45dCk73YDIaVi5PSB8PAOKNIRz40FfpZZLQd3oC","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}